Oxford Biomedica plc announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was GBP 81.252 million compared to GBP 33.979 million a year ago. Operating income was GBP 19.658 million compared to operating loss of GBP 5.766 million a year ago. Net income was GBP 18.069 million compared to net loss of GBP 6.679 million a year ago. Basic earnings per share from continuing operations was GBP 0.2192 compared to basic loss per share from continuing operations of GBP 0.0869 a year ago. Diluted earnings per share from continuing operations was GBP 0.2136.